Role of CPAP treatment in elderly with moderate obstructive sleep apnea

C. De Juana Izquierdo (Valencia, Spain), S. Ponce (Valencia, Spain), E. Pastor (Alicante, Spain), B. Orosa (Valencia, Spain), G. Oscullo (Valencia, Spain), P. Catalán (Valencia, Spain), A. Martínez (Castellón, Spain), L. Hernández (Alicante, Spain), E. Chiner (Alicante, Spain), M. Martínez (Valencia, Spain)

Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Session: Treatment of continuous positive airway pressure and monitoring of its effects
Session type: Thematic Poster
Number: 4152
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. De Juana Izquierdo (Valencia, Spain), S. Ponce (Valencia, Spain), E. Pastor (Alicante, Spain), B. Orosa (Valencia, Spain), G. Oscullo (Valencia, Spain), P. Catalán (Valencia, Spain), A. Martínez (Castellón, Spain), L. Hernández (Alicante, Spain), E. Chiner (Alicante, Spain), M. Martínez (Valencia, Spain). Role of CPAP treatment in elderly with moderate obstructive sleep apnea. 4152

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Control of breathing in obstructive sleep apnoea patients: Role of CPAP therapy
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009

Long-term CPAP compliance in women with obstructive sleep apnoea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009

Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012


Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 97s
Year: 2003

Effect of obstructive sleep apnea on asthma control
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020


Telecoaching to improve physical activity in patients with obstructive sleep apnea treated with CPAP
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004

The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


The role of bi-level therapy in obstructive sleep apnoea
Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing
Year: 2008


Determinants of CPAP compliance in bariatric patients with obstructive sleep apnoea
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017

Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002

Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 103s
Year: 2002

Predictors of hypercapnia in obstructive sleep apnoea (OSA)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010

Effects of nCPAP treatment on quality of life of patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 410s
Year: 2006

Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea
Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Year: 2019


Effect of multiple-dose treatment with daridorexant on nighttime respiratory function in patients with mild and moderate obstructive sleep apnea (OSA)
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020


CPAP improves chronic cough in patients with obstructive sleep apnoea – a pilot study
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008

Improving adherence to treatment in patients with obstructive sleep apnoea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019